In a major personnel shift, UnitedHealth Group (NYSE:UNH) announced this week that Larry Renfro, CEO of its subsidiary Optum, will step away from the corner office to lead Optum Ventures and its new $100 million global investment fund.
Ex-GlaxoSmithKline (NYSE:GSK) chief executive, Andrew Witty, will take Renfro’s place as CEO of Optum on July 1, according to the company. Witty has been a member of UnitedHealth’s board since August of 2017.
Get the full story at our sister site, Medical Design & Outsourcing.
The post Optum CEO Renfro steps down to lead expanded investment fund appeared first on MassDevice.
from MassDevice http://ift.tt/2pk1SXO
Cap comentari:
Publica un comentari a l'entrada